One of the major goals of researchers in the field of apoptosis is to identify targets for novel therapies in cancer, AIDS, and Alzheimer's disease. Understanding the molecular mechanisms of the various components of the apoptotic pathways is the first step to reaching this goal. The 2002 Nobel Prize in Physiology or Medicine was awarded to Sydney Brenner (United Kingdom), H. Robert Horvitz (US) and John E. Sulston (UK) "for their discoveries concerning genetic regulation of organ development and programmed cell death." Cell death is a fundamental aspect of embryonic development, normal cellular turnover and maintenance of homeostasis (maintaining a stable, constant environment) on the one hand, and aging and disease on the other. This volume addresses the significant advances with the techniques that are being used to analyze cell death.
- This volume provides the necessary, trusted methods to carry out this research on these latest therapeutic techniques. Once researchers understand the molecular mechanisms of the apoptotic pathways, they can begin to develop new therapies
- Presents key methods on studying tumors and how these cancer cells evade cell death
- Eliminates searching through many different sources to avoid pitfalls so the same mistakes are not made over and over
Inhaltsverzeichnis
1;Cover;1 2;Copyright Page;5 3;TOC$Contents;6 4;Contributors;14 5;Preface;22 6;Volume in Series;22 7;CH$Chapter 1: Analysis of Autophagic and Necrotic Cell Death in Dictyostelium;50 7.1;1. Introduction;51 7.2;2. Growing Dictyostelium Cells in Monolayer Cultures;52 7.3;3. Inducing Autophagic Vacuolar Cell Death;53 7.4;4. Further Exploration of Autophagic Cell Death;55 7.5;5. Inducing Necrotic Cell Death;59 7.6;6. Further Exploration of Necrotic Cell Death;59 7.7;References;62 8;CH$Chapter 2: Methods and Protocols for Studying Cell Death in Drosophila;66 8.1;1. Introduction;67 8.2;2. Cell Death Analysis During Development;71 8.3;3. Biochemical Analysis;76 8.4;4. Genetic Analysis;80 8.5;References;84 9;CH$Chapter 3: In Vivo and In Vitro Methods for Studying Apoptotic Cell Engulfment in Drosophila;88 9.1;1. Introduction;89 9.2;2. Culture Conditions;90 9.3;3. Labeling of Apoptotic Cells;92 9.4;4. Visualizing the Macrophages;95 9.5;5. Quantification and Statistics;99 9.6;6. Engulfment in Cell Culture;101 9.7;Acknowledgments;106 9.8;References;106 10;CH$Chapter 4: A Mouse Mammary Epithelial Cell Model to Identify Molecular Mechanisms Regulating Breast Cancer Progression;110 10.1;1. Introduction;111 10.2;2. A Novel Mouse Mammary Epithelial Cell Model;112 10.3;3. Protocols;114 10.4;4. Concluding Remarks;123 10.5;References;123 11;CH$Chapter 5: Immortalized Mouse Epithelial Cell Models to Study the Role of Apoptosis in Cancer;126 11.1;1. Introduction;127 11.2;2. Immortalization of Baby Mouse Kidney, Mammary, Prostate, and Ovarian Surface Epithelial Cells;130 11.3;3. Development of iBMK Cell Lines for Identifying the Role of Apoptosis in Cancer;143 11.4;4. Aposcreen: An iBMK Cell-Based Screen for the Identification of Apoptosis-Inducing Compounds as Potential Anti-Cancer Agents;144 11.5;5. Adaptation of the iBMK Cell Model System for the Evaluation of Tissue-Specific Tumor-Promoting Functions;146 11.6;6. Tumorigenicity Assay;149 11.7;7. Noninvasive In Vivo Monitoring of Tumor
Growth by Expression of Fluorescence and Chemiluminescence Markers;151 11.8;8. Tumor-Derived Cell Lines (TDCLs) as a Model System for Epithelial Tumor-Promoting Functions;152 11.9;9. Concluding Remarks and Future Perspectives;153 11.10;Acknowledgments;154 11.11;References;154 12;CH$Chapter 6: DNA Damage Response and Apoptosis;156 12.1;1. Introduction;157 12.2;2. Methods;159 12.3;Notes;168 12.4;Acknowledgments;169 12.5;References;169 13;CH$Chapter 7: Phorbol Ester-Induced Apoptosis and Senescence in Cancer Cell Models;172 13.1;1. Introduction;173 13.2;2. PKCdelta as a Pro-Apoptotic Kinase;173 13.3;3. PKCdelta as a Mediator of Apoptotic Responses in Prostate Cancer Cells: The Emergence of an Autocrine Paradigm;174 13.4;4. Roles of PKCalpha and PKCepsilon LNCAP Cell Death and Survival;176 13.5;5. Regulation of Cell Cycle and Senescence by PKC;177 13.6;6. Determination of Phorbol Ester-Induced Apoptosis in Prostate Cancer Cells;178 13.7;7. Adenoviral Expression of PKC Isozymes;180 13.8;8. RNA Interference of PKC Isozymes;181 13.9;9. Collection and Storage of CM from LNCaP Cells;182 13.10;10. Determination of Senescence in Response to Phorbol Esters;183 13.11;References;185 14;CH$Chapter 8: Manipulation of PKC Isozymes by RNA Interference and Inducible Expression of PKC Constructs;190 14.1;1. Introduction;190 14.2;2. Methods;192 14.3;Acknowledgments;204 14.4;References;204 15;CH$Chapter 9: Studying p53-Dependent Cell Death In Vitro and In Vivo;208 15.1;1. Introduction;208 15.2;2. Studying p53-Dependent Cell Death In Vitro;209 15.3;3. Overexpression of p53 by Adenovirus (Ad);209 15.4;4. Silencing the p53 Gene by Retroviral Vector;213 15.5;5. Studying the Apoptotic Response;214 15.6;6. Studying p53-Dependent Apoptosis In Vivo;214 15.7;References;221 16;CH$Chapter 10: NF-kappaB as a Determinant of Distinct Cell Death Pathways;224 16.1;1. Introduction;225 16.2;2. Methods;227 16.3;3. DNA;229 16.4;4. Proteins;232 16.5;5. Metabolic Health;233 16.6;6. Senescence Detection;234 16
.7;References;235 17;CH$Chapter 11: Purification and Bioassay of Hedgehog Ligands for the Study of Cell Death and Survival;238 17.1;1. Introduction;239 17.2;2. Hedgehog and the Regulation of Cell Death;242 17.3;3. Generation of Recombinant Hedgehog Ligands;244 17.4;References;250 18;CH$Chapter 12: Experimental Approaches to Investigate the Proteasomal Degradation Pathways Involved in Regulation of Apoptosis;254 18.1;1. Introduction;255 18.2;2. General Instructions;256 18.3;3. Protocols;256 18.4;References;271 19;CH$Chapter 13: Ubiquitination Mediated by Inhibitor of Apoptosis Proteins;274 19.1;1. Introduction;274 19.2;2. In Vitro Ubiquitination Assay;275 19.3;3. In Vivo Ubiquitination Assay;281 19.4;Acknowledgments;283 19.5;References;283 20;CH$Chapter 14: Phosphatases and Regulation of Cell Death;286 20.1;1. Introduction;287 20.2;2. Identification of the Putative Phosphatase in Cells;289 20.3;3. In Vitro Phosphatase Assays;297 20.4;4. Interaction of the Phosphatase and Apoptotic Protein;298 20.5;5. Linking Phosphatase Activity to Cell Death Protein Function;302 20.6;6. Conclusion;304 20.7;Acknowledgments;304 20.8;References;304 21;CH$Chapter 15: Analysis of Neuronal Cell Death in Mammals;308 21.1;1. Introduction;309 21.2;2. Apoptosis Detection In Vitro;309 21.3;3. Assessment of Cell Death;311 21.4;4. Apoptosis Detection in Brain Development;318 21.5;5. Detection of Synaptic Apoptosis (Synaptosis);321 21.6;6. Conclusions;324 21.7;Acknowledgments;324 21.8;References;324 22;CH$Chapter 16: Dissecting Apoptosis and Intrinsic Death Pathways in the Heart;326 22.1;1. Introduction;327 22.2;2. Protocols;328 22.3;Acknowledgments;332 22.4;References;333 23;CH$Chapter 17: Quantification of Vascular Endothelial Cell Apoptosis In Vivo;336 23.1;1. Introduction;336 23.2;2. Protocols;337 23.3;References;341 24;CH$Chapter 18: Recombinant TRAIL and TRAIL Receptor Analysis;342 24.1;1. Introduction;343 24.2;2. Generation of Recombinant TRAIL;344 24.3;3. Analysis of TRAIL Receptors;351 2
4.4;4. Concluding Remarks;360 24.5;Acknowledgments;360 24.6;References;361 25;CH$Chapter 19: Analysis of Tnf-Related Apoptosis-Inducing Ligand In Vivo Through Bone Marrow Transduction and Transplantation;364 25.1;1. Introduction;365 25.2;2. Generation of Retroviral Infection Medium;366 25.3;3. Bone Marrow Cell Preparation;367 25.4;4. Retroviral Transduction of Bone Marrow Cells;368 25.5;5. Bone Marrow Transplantation;370 25.6;6. Assessment of Bone Marrow Transplantation;371 25.7;7. Pathologic Evaluation of TRAIL-Transduced Mice;372 25.8;8. Methods for Immunohistochemical Staining for TRAIL Expression;375 25.9;9. Applications that Use the Bone Marrow Transplantation Approach;377 25.10;Acknowledgments;378 25.11;References;378 26;CH$Chapter 20: Overcoming Resistance to Trail-Induced Apoptosis in Prostate Cancer by Regulation of c-FLIP;382 26.1;1. Introduction;383 26.2;2. Structure and Molecular Mechanisms of c-FLIP in Apoptosis;383 26.3;3. Expression of c-FLIP;384 26.4;4. Regulation of c-FLIP Expression;386 26.5;5. Targeting c-FLIP to Enhance Apoptosis in Cancer Cells;390 26.6;6. Methods and Materials;391 26.7;Acknowledgments;395 26.8;References;395 27;CH$Chapter 21: Caspase Assays: Identifying Caspase Activity and Substrates In Vitro and In Vivo;400 27.1;1. Introduction;401 27.2;2. Caspase Methods;402 27.3;3. Conclusion;414 27.4;References;415 28;CH$Chapter 22: Synthesis and Biophysical Characterization of Stabilized alpha-Helices of BCL-2 Domains;418 28.1;1. Introduction;419 28.2;2. Synthesis of Non-Natural Amino Acids for Peptide Stapling;421 28.3;3. Design and Synthesis of Stabilized alpha-Helices of BCL-2 Domains (SAHBs);422 28.4;4. Structural Assessment of SAHBs by Circular Dichroism (CD);425 28.5;5. Protease Resistance Testing of SAHBs;427 28.6;6. Cell Permeability Screening of SAHBs;430 28.7;7. Summary;432 28.8;Acknowledgments;433 28.9;References;433 29;CH$Chapter 23: Dissection of the BCL-2 Family Signaling Network with Stabilized alpha-Helices of BCL-2 Domain
s;436 29.1;1. Introduction;437 29.2;2. BCL-2 Family Binding Measurements by Fluorescence Polarization Assay;437 29.3;3. In Vitro Release Assays as a Measure of Pro-Apoptotic Activity;441 29.4;4. Measurement of Cellular Apoptosis Induction;449 29.5;5. Identification of In Situ Mechanistic Targets of SAHBs;452 29.6;6. Summary;454 29.7;Acknowledgments;454 29.8;References;454 30;CH$Chapter 24: ERM-Mediated Genetic Screens in Mammalian Cells;458 30.1;1. Introduction;458 30.2;2. Methods and Design;460 30.3;3. ERM-Mediated Genetic Screens and Re-PCA;464 30.4;4. Conclusions;466 30.5;Acknowledgments;467 30.6;References;467 31;Author Index;470 32;IDX$Subject Index;494 33;Color Plate Section;500